Trevor Phillips
Director/Board Member chez TISSUE REGENIX GROUP PLC
Fortune : 43 706 $ au 31/03/2024
Profil
Trevor Michael Phillips currently works at NEPeSMO Ltd., as Chairman, Tissue Regenix Group Plc, as Independent Non-Executive Director from 2021, and Imutex Ltd., as Director from 2018.
Dr. Phillips also formerly worked at Critical Therapeutics, Inc., as President & Chief Executive Officer in 2008, Cornerstone Therapeutics, Inc., as President & Chief Executive Officer, hVIVO PLC, as Chief Executive Officer in 2020, hVIVO Ltd., as Executive Chairman from 2017 to 2020, Sumitomo Pharma America, Inc., as Senior Program Director from 2001 to 2002, Glaxo Wellcome Plc, as Director-Strategic Direction from 1990 to 1997, Vectura Group Ltd., as Executive Director in 2017, Scotia Holdings Plc, as Director-Drug Development, Strategy & Planning from 1999 to 2001, Morvus Technology Ltd., as Non-Executive Director, Vectura GmbH, as Chief Operations Officer & Director, hVIVO Services Ltd., as Non-Executive Director in 2017, Accenture Ltd., as Senior Manager-Strategic Planning from 1997 to 1999, and Simbec Research Ltd., as Head-Research & Development.
Dr. Phillips received his undergraduate degree from The University of Reading, doctorate degree in 1986 from the University of Wales (Bangor), Masters Business Admin degree from Henley Management College, and doctorate degree from Swansea University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
TISSUE REGENIX GROUP PLC
0,08% | 31/12/2023 | 55 357 ( 0,08% ) | 43 706 $ | 31/03/2024 |
Postes actifs de Trevor Phillips
| Sociétés | Poste | Début |
|---|---|---|
| TISSUE REGENIX GROUP PLC | Director/Board Member | 05/01/2021 |
| NEPeSMO Ltd. | Chairman | - |
Imutex Ltd.
 Imutex Ltd. BiotechnologyHealth Technology Imutex Ltd. is a British company that develops vaccines. The joint venture company is based in London, UK. | Director/Board Member | 27/04/2018 |
Anciens postes connus de Trevor Phillips
| Sociétés | Poste | Fin |
|---|---|---|
| HVIVO PLC | Chief Executive Officer | 01/06/2020 |
| HVIVO PLC | Chairman | 01/01/2020 |
| VECTURA GROUP | Chief Operating Officer | 25/05/2017 |
| Critical Therapeutics, Inc. | President | 31/10/2008 |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Corporate Officer/Principal | 01/09/2002 |
Formation de Trevor Phillips
| The University of Reading | Undergraduate Degree |
| University of Wales (Bangor) | Doctorate Degree |
| Henley Management College | Masters Business Admin |
| Swansea University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TISSUE REGENIX GROUP PLC | Health Technology |
| HVIVO PLC | Commercial Services |
| Entreprise privées | 14 |
|---|---|
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
Accenture Ltd.
 Accenture Ltd. Miscellaneous Commercial ServicesCommercial Services Accenture Ltd. provides services to management consulting, technology services and outsourcing organizations. It provides management consulting, technology, systems integration and outsourcing services and solutions to the communications, electronics, high technology, media and entertainment industries. The company was founded in 1984 and is headquartered in Hamilton, Bermuda. | Commercial Services |
| Critical Therapeutics, Inc. | Health Technology |
Vectura Group Ltd.
 Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Vectura Group Ltd. engages in the provision of pharmaceutical development. Its activities include research, development, and commercialization of novel therapeutic products. The company operates through the following segments: Switzerland, United Kingdom, Germany, United States of America, and France. Vectura Group was founded by David Anthony Gough in 1997 and is headquartered in Chippenham, the United Kingdom. | Health Technology |
hVIVO Ltd.
 hVIVO Ltd. Miscellaneous Commercial ServicesCommercial Services hVIVO Ltd. engages in the provision of clinical development services with a focus on human disease models. It specializes in human challenge studies using influenza, human rhinovirus, and respiratory syncytial virus for pharmaceutical and biotech companies. The company was founded by John Sidney Oxford in 1989 and is headquartered in London, the United Kingdom. | Commercial Services |
| Scotia Holdings Plc | Commercial Services |
Simbec Research Ltd.
 Simbec Research Ltd. Miscellaneous Commercial ServicesCommercial Services Simbec Research Ltd. provides clinical research service to pharmaceutical and biotechnology industries. It conducts drug trails for allergy, anti-infectives, cardiovascular, gastrointestinal, anti-inflammatory, oncology and respiratory. The firm also offers consultancy services, preparation of marketing authorization applications, and clinical trial applications. The company was founded in 1976 and is headquartered in Merthyr Tydfil, the United Kingdom. | Commercial Services |
Morvus Technology Ltd.
 Morvus Technology Ltd. Pharmaceuticals: GenericHealth Technology Morvus Technology Ltd. discovers, develops and commercializes of novel drugs and technologies in the oncology field. Its products include clinical candidates, research portfolio and non-core programmes. The company was founded by Philip John Burke and Roger Geoffrey Melton in April 2004 and is headquartered in Carmarthen, the United Kingdom. | Health Technology |
Cornerstone Therapeutics, Inc.
 Cornerstone Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cornerstone Therapeutics, Inc. operates as a pharmaceutical company. The firm engages in the development and commercialization of products for the hospital, rare disease and adjacent specialty care settings. It acquires, develops and commercializes prescription pharmaceutical drugs. The company was founded on October 31, 2008 and is headquartered in Cary, NC. | Health Technology |
hVIVO Services Ltd.
 hVIVO Services Ltd. Internet Software/ServicesTechnology Services Part of hVIVO PLC, hVIVO Services Ltd. is a British company that specializes in full-service viral challenge studies. The private company is based in London, UK. The company's services include challenge models and lab services. The company was founded in 1988 by John Sidney Oxford. | Technology Services |
Imutex Ltd.
Imutex Ltd. BiotechnologyHealth Technology Imutex Ltd. is a British company that develops vaccines. The joint venture company is based in London, UK. | Health Technology |
| NEPeSMO Ltd. | |
Vectura GmbH
 Vectura GmbH Medical SpecialtiesHealth Technology Vectura GmbH manufactures and develops pharmaceutical therapies for airways diseases. It offers dry powder formulation technology, device technology, and development capabilities. The company was founded by Gerhard Scheuch in 1997 and is headquartered in Gemünden, Germany. | Health Technology |
